Policy & Regulation
Camargo Pharmaceutical Services announces Paidion Research acquisition
3 March 2021 -

Camargo Pharmaceutical Services LLC, a United States-based drug development and commercial partner, is acquiring Paidion Research Inc, a global paediatric clinical research organisation in the United States, it was reported on Tuesday.

Camargo says that this is its second acquisition to expand services in order to offer leading integrated solutions designed to meet the requirements of emerging biopharma companies addressing unmet medical requirements in rare and complex areas.

Camargo CEO, Dan Duffy, said, 'Half of all patients affected by a rare disease are children. Paediatric research is critical to success as we work to deliver a comprehensive solution to emerging biopharma companies with specialised needs. We are proud to partner with the Paidion team, who have earned their reputation as the leader in paediatric clinical research.'